STAT News · Scour

STAT+: FDA approves leucovorin for rare disorder without trial data

statnews.com·9w

STAT+: Pharmalittle: We’re reading about the FDA warning Novo Nordisk, Lilly investing in China, and more

statnews.com·9w

STAT+: This billionaire wants to make science better, especially for AI

statnews.com·9w

Red states hit hardest by reduced NIH funding

statnews.com·9w

STAT+: New nonprofit launches with at least $500 million to modernize scientific process for AI era

statnews.com·9w

Opinion: I’m a medical student. RFK Jr. is right about medical school and preventive care

statnews.com·9w

STAT+: AI agents are rapidly spreading in health care, but validation is lacking

statnews.com·9w

STAT+: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback

statnews.com·9w

STAT+: GOP senator is investigating the FDA over rejections of rare disease drugs

statnews.com·9w

STAT+: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again

statnews.com·9w

STAT+: What’s next for RFK Jr.’s MAHA allies on vaccine policy?

statnews.com·9w

Leucovorin lacks evidence to use as autism treatment, FDA says

statnews.com·9w

STAT+: Novo Nordisk is warned by the FDA for failing to report side effects

statnews.com·9w

Health AI startup to benefit from $1 billion funding round for Yann LeCun’s AMI

statnews.com·9w

STAT+: Pharmalittle: We’re reading about a U.S. senator probing FDA, BioNTech founders leaving, and much more

statnews.com·9w

Amid dueling autism meetings, HHS cancels

statnews.com·9w

STAT+: BioNTech founders to depart, form new mRNA-focused company

statnews.com·9w·Hacker News

STAT+: Large drugmakers are developing fewer antibiotics, analysis finds

statnews.com·9w

Removing race from kidney function algorithm helped more Black patients access transplants

statnews.com·9w

Opinion: STAT+: The Himsification of medicine

statnews.com·9w

Log in to enable infinite scrolling